Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical

Douglas Grossman1,2,3, Nwanneka Okwundu1, Edmund K Bartlett4

  • 1Huntsman Cancer Institute, Salt Lake City, Utah.

JAMA Dermatology
|July 30, 2020
PubMed
Summary

Gene expression profile (GEP) testing for cutaneous melanoma shows promise but requires more evidence for routine use. Current GEP tests have limitations, especially for early-stage disease, necessitating further research before widespread clinical adoption.